Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 19.11% | -18.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.11% | -18.63% | |||
| Cost of Revenue | 5.96% | -28.47% | |||
| Gross Profit | 33.24% | -4.54% | |||
| SG&A Expenses | -1.77% | 9.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.76% | -8.76% | |||
| Operating Income | 48.33% | -35.14% | |||
| Income Before Tax | 44.10% | -24.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.10% | -24.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.10% | -24.55% | |||
| EBIT | 48.33% | -35.14% | |||
| EBITDA | 76.87% | -36.95% | |||
| EPS Basic | 44.00% | -25.00% | |||
| Normalized Basic EPS | 44.68% | -23.68% | |||
| EPS Diluted | 42.67% | -25.00% | |||
| Normalized Diluted EPS | 44.68% | -23.68% | |||
| Average Basic Shares Outstanding | -0.79% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.83% | -0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||